glp-1 tirzepatide Associated with Lower POAG, OHT Risk Compared with Other Drugs Lose up to 20% of your body weight with this simple Tirzepatide is NO longer in

Most people lose weight with continued treatment after a few months

Recently, studies have focused on the effect of GLP-1s on the brain, showing that they affect food cognition, depression, drug addiction, and even neurodegenerative diseases

Patients will be excluded (1) if they have had a heart attack, stroke, hospitalization for congestive heart failure or unstable angina within 90 days before screening, (2) if they have been taking any weight loss drugs, including over-the-counter medications, within 90 days before screening, (3) if they have had a change in body weight greater than 11 pounds within 90 days, (4) if they have or are planning a surgical treatment for excess weight, (5) if they have Type 1 Diabetes Mellitus, (6) if they have a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN-2) and (7) if they have had pancreatitis

and (3) experimental studies

10.3390/ph17020199 5 ArdJ.FitchA.FruhS.HermanL

there was no observed benefit in liraglutide treated patients compared to placebo in primary outcome (62)